Grant: Discovery Grants Program - Individual

From the creation of an mRNA transcript to the degradation of the protein it encodes, there are a multitude of regulatory steps in eukaryotic gene expression. One essential step in this process is pre-mRNA splicing, in which interrupting sequences are removed from nascent transcripts. Through alternative inclusion of mRNA regions, pre-mRNA splicing dramatically broadens the range of proteins encoded by a particular gene, and provides additional regulatory layers that allow a cell to respond to environmental conditions, developmental signals, and cell cycle progression. Our understanding of this process, however, comes from a very limited range of model organisms with a strong taxonomic bias towards metazoans and fungi. Published results: Human and yeast splicing systems have proven intractably complex for detailed mechanistic studies. I hypothesized that an extremophile with a small genome might have a simpler set of splicing machinery. With my students, I have identified in the unicellular red alga C. merolae a dramatically simpler spliceosome consisting of only ~40 core proteins and four snRNAs. Strikingly, it is the first organism demonstrated to lack the U1 snRNP, the splicing particle that normally carries out the first step of substrate recognition. Objectives: My long-term objectives are to determine the role of each splicing component in C. merolae, as well as to understand the regulation, biological consequences, and evolution of splicing. My short-term objectives are to exploit the power of our simplified splicing system by determining structures of its components and investigating their function. Scientific approach: We will use a battery of new C. merolae-specific reagents to isolate and characterize splicing complexes and to study how splicing decisions alter the fitness of C. merolae under different conditions. Aim #1: purify and characterize endogenous complexes and test their function in binding substrates and catalyzing splicing. Aim #2: determine whether and how splicing is regulated in C. merolae. Aim #3: investigate the biological relevance of splicing by using CRISPR-Cas9 to delete introns and measure the effect on growth and stress responses. Feasibility: Complementing years of splicing biochemistry in yeast, we have successfully isolated and characterized splicing complexes from C. merolae in published experiments. In addition, we have developed a number of reagents (antibodies, transformation methods, morpholino oligos) that will be required for the proposed work. Novelty and significance: With C. merolae, my lab is developing the first new model system for studying splicing in years, and a unique system for its simplicity and evolutionary implications. These discoveries will have broadly felt impacts on technologies based on gene expression, a wide range of human and animal diseases, and fundamental questions of how splicing has evolved.